文章核心观点 - 公司是先进疗法领域的领导者,专注于运动医学和严重烧伤护理市场 [1][4] - 公司将生物学创新与医疗技术相结合,拥有高度差异化的创新细胞疗法和专业生物制品组合,可修复伤害并恢复生命 [4] - 公司在美国销售三种产品:MACI、Epicel和NexoBrid [4] 根据相关目录分别进行总结 财务报告 - 公司将于2024年8月1日报告2024年第二季度的财务业绩 [1] - 公司管理层将于当天上午8:30(ET)召开电话会议和网络广播,讨论财务业绩和业务亮点 [1][2] 投资者信息 - 可在公司投资者关系网站上实时观看网络广播 [2] - 网络广播演示文稿也将在投资者关系网站上提供 [2] - 可通过电话参与会议,需要先进行注册以获取拨入详细信息和个人密码 [3] - 网络广播重播将在公司网站上提供至2025年8月1日 [3] 公司概况 - 公司是运动医学和严重烧伤护理市场的领先提供商 [4] - 公司在美国销售三种产品:MACI、Epicel和NexoBrid [4] - MACI是一种用于修复膝盖软骨缺损的自体细胞支架产品 [4] - Epicel是一种永久性皮肤替代品,用于治疗30%以上全身面积的深层皮肤或全层烧伤患者 [4] - 公司还拥有NexoBrid的北美独家许可权,这是一种用于去除成人深部部分厚度和/或全厚度烧伤的生物孤儿产品 [4]

CAMBRIDGE, Mass., June 11, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, and Joe Mara, CFO, will participate in a fireside chat at the Truist Securities MedTech Conference at 2:30 p.m. ET on Tuesday, June 18, 2024. A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel ...

CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference at 9:40 a.m. ET on Wednesday, May 29, 2024. A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://inv ...

CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO and Joe Mara, CFO will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference at 9:40 a.m. ET on Wednesday, May 29, 2024. A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://inv ...

VERICEL Q1 2024 RESULTS MAY 8, 2024 Safe Harbor Vericel cautions you that all statements other than statements NexoBrid®, growth in profit, gross margins and operating future impacts on our business or the economy generally of historical fact included in this presentation that address margins, the ability to continue to scale our manufacturing stemming from a resurgence of COVID-19 or another similar activities, events or developments that we expect, believe or operations to meet the demand for our cell the ...

Vericel Corporation (NASDAQ:VCEL) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Eric Burns - Vice President of Finance & Investor Relations Nick Colangelo - Chief Executive Officer Joe Mara - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Sam Brodovsky - Truist Securities George Sellers - Stephens, Inc. Swayampakula Ramakanth - H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by. Welcome to Vericel's First Quarter 2024 Conferenc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35280 VERICEL CORPORATION (Exact name of registrant as specified in its charter) Michigan 94-3096597 (State or other jurisdiction of incorporation or organization) (I.R.S. ...

Exhibit 99.1 Vericel Corporation 64 Sidney Street Cambridge, MA 02139 T 617 588-5555 F 617 588-5554 www.vcel.com Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance Total Revenue Increased 25% to $51.3 Million Record First Quarter MACI Revenue of $40.2 Million and Burn Care Revenue Growth of 63% Adjusted EBITDA Growth of 325% Full-Year 2024 Revenue Guidance Raised to $238-$242 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 8, 2024 (GL ...

VERICEL Q4 2023 RESULTS FEBRUARY 29, 2024 Safe Harbor Vericel cautions you that all statements other than revenue, growth in revenue, market penetration for institutions, companies in the financial services industry statements of historical fact included in this presentation MACI®, Epicel®, and NexoBrid®, growth in profit, gross or the financial services industry generally, global that address activities, events or developments that we margins and operating margins, the ability to continue to geopolitical t ...

Vericel Corporation (NASDAQ:VCEL) Q4 2023 Earnings Conference Call February 29, 2024 8:30 AM ET Company Participants Julie Downs - Head, Corporate Communications Nick Colangelo - President and CEO Joe Mara - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Mike Kratky - Leerink Partners Sam Brodovsky - Truist Securities George Sellers - Stephens Jeffrey Cohen - Ladenburg Swayampakula Ramakanth - HCW Operator Ladies and gentlemen, thank you for standing by. Welcome to Vericel’s Four ...